Paul van Donkelaar, Ph.D.
Motor Control
Eye/Hand Analysis Lab: http://www.uoregon.edu/~paulvd/eyehandlab
Email: paulvd@uoregon.edu
Paul van Donkelaar's research focuses on the neural control of human movement. He has approached this issue using behavioral, transcranial magnetic stimulation, and functional magnetic resonance imaging studies in healthy humans and in patients suffering from a number of different neurological syndromes including stroke, concussion, and cerebral palsy. The aim is to provide a better understanding of the processes by which sensory and motor systems interact with the hope that this knowledge can be used to develop better rehabilitative therapies for patients with a variety of motor deficits. Dr. van Donkelaar received a Ph.D. in clinical neuroscience from the University of Calgary in Canada in 1994. He spent the following year as an NSERC post-doctoral fellow at the Universite de Provence in Marseille, France. Prior to coming to the University of Oregon, he held a position as post-doctoral research scientist from 1995 to 1997 in the Department of Physiology at the University of Oxford in England.
Education
Ph.D. – Clinical Neuroscience, 1994 – University of Calgary, Calgary
M.P.E. – Physical Education, 1990 – University of B.C.
B.P.E – Physical Education, 1987 – University of B.C.
Professional Organizations
Member: Society for Neuroscience
Professional Service
Dr. van Donkelaar is on the Editorial Board of the Journal of Motor Behavior and is a reviewer for many different journals including the Journal of Neuroscience, Cerebral Cortex, Brain, Journal of Neurophysiology, Journal of Physiology, and NeuroImage. He is also a panelist on the Motor Function, Speech, and Rehabilitation NIH Study Section.
Dr. van Donkelaar has published over 50 research articles that have appeared in journals such as the Journal of Neuroscience, Brain, Cerebral Cortex, Journal of Neurophysiology, and Experimental Brain Research. He has also given invited presentations at a variety of universities and research institutes including INSERM, France; University of Wales; Simon Fraser University, Canada; University of Queensland, Australia; Queen’s University, Canada; University of Maryland; University of British Columbia, Canada; and University of Bern, Switzerland;. His research has been funded by the National Science Foundation, American Heart Association, Centers for Disease Control, and the NIH.